BRIEF

on FIS

FIS Completes €770 Million Bond Issuance

FIS, a prominent Italian producer of active pharmaceutical ingredients, has finalized a €770 million bond issuance. The offering included €300 million in fixed-rate notes at 5.250% interest and €470 million in floating-rate notes with a rate tied to Euribor. These notes, admitted for trading on the Luxembourg Stock Exchange, mature in February 2031.

This bond issuance was met with substantial oversubscription, indicating strong investor confidence in FIS's strategic and financial positioning. The proceeds will enhance liquidity and financial flexibility, supported by an increased revolving credit facility.

Recent upgrades from Moody's and Fitch Ratings reaffirm the financial stability of FIS. Daniele Piergentili, FIS CEO, cites this transaction as affirming market confidence in their business model.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all FIS news